Yannes v. SCWorx Corp. et al

  1. February 14, 2022

    Contractor, Investors Reach $3.3M Deal In COVID Tests Suit

    Investors in SCWorx Corp. have reached a $3.3 million settlement with the health care logistics company to resolve claims that it misled investors when it announced a major COVID-19 test kit contract in the early days of the pandemic.

  2. November 19, 2020

    Contractor Fights Investors' Claims Over COVID Test Kit Deal

    Hospital contractor SCWorx and its chief executive told a Manhattan federal judge on Wednesday that a proposed class of investors failed to show that the company had lied in connection with a COVID-19 test supply deal that purportedly fell apart in the spring.

  3. September 18, 2020

    Kaplan Fox Nabs Lead In Investors' Rapid Virus Tests Suit

    Kaplan Fox & Kilsheimer LLP will represent a proposed class of investors in a suit alleging hospital contractor SCWorx "overstated or entirely fabricated" its announcement in April that it would soon earn millions weekly by supplying COVID-19 rapid testing kits.

  4. June 30, 2020

    Legal Teams Vie To Lead COVID Test Supply Stock Drop Suit

    Four legal teams are competing to represent a proposed class of investors in Manhattan federal court suit accusing health care analytics company SCWorx Corp. of securities fraud after the firm landed on a list of public companies subject to U.S. Securities and Exchange Commission trading suspensions linked to claims about combating coronavirus.

  5. May 29, 2020

    COVID-19 Securities Catch-Up: The 8 Biggest Investor Actions

    At least 50 federal securities cases with references to COVID-19 have been filed in the past three months, including merger challenges, regulatory enforcement actions and sprawling investor suits, according to a Law360 review of filings. As the pandemic pushes into the summer, Law360 is taking a look at eight major investor actions that were brought in connection with the novel coronavirus since March.

  6. April 30, 2020

    'Bogus' COVID-19 Test-Kit Deal Draws Investor Fraud Lawsuit

    Investors slapped a health care supplier with a proposed securities fraud class action on Wednesday, claiming it misled them by boasting it was poised to sell millions of COVID-19 rapid testing kits in a deal that turned out to be backed by alleged fraudsters and convicted felons.